They have not been studied in the clinical trials behind those medications
Understanding GLP-1 and Its Role in Weight Management GLP-1, or Glucagon-Like Peptide-1, is a hormone that plays a crucial role in managing blood sugar levels and appetite
Several pieces of evidence have demonstrated that GIP administration results in an improved glucose-dependent insulin secretion [30, 31]
Despite the overwhelming success of GLP-1 medications related to weight loss, GLP-1 therapy is associated with increased cerebral blood flow and reduced small-vessel disease burden, even when controlling for weight loss [15]
Ideal candidates for GLP-1 injections are adults who are clinically obese (BMI of 30 or higher) or those who are overweight (BMI of 27 or higher) and have one or more weight-related health conditions, such as high blood pressure or diabetes
Western Europe: In Western Europe, Germany is a key market for GLP-1 receptor agonists, driven by the growing demand for effective diabetes treatments and the countrys strong healthcare system
